PHIO logo

PHIO
Phio Pharmaceuticals Corp

18,829
Mkt Cap
$12.9M
Volume
108,022.00
52W High
$4.19
52W Low
$0.8127
PE Ratio
-0.77
PHIO Fundamentals
Price
$1.11
Prev Close
$1.14
Open
$1.14
50D MA
$1.19
Beta
1.22
Avg. Volume
142,030.84
EPS (Annual)
-$1.45
P/B
0.78
Rev/Employee
$0.00
$14.75
Loading...
Loading...
News
all
press releases
Best Value Stocks to Buy for May 28th
Zacks
News Placeholder
More News
News Placeholder
New Strong Buy Stocks for May 28th
Zacks
News Placeholder
Phio Pharmaceuticals Stock Soars On Clearance To Escalate Dose In Skin Cancer Treatment Trial: Retail’s Thrilled
CEO Robert Bitterman said the company is optimistic that the clinical trial will continue to demonstrate that PH-762 may present a viable non-surgical alternative to existing modes of therapy for skin cancer.
Stocktwits
News Placeholder
We Asked Retail What's Next For Phio Pharma After Monday's Blistering Rally: Most See More Room To Run
Around 34% foresee a pullback, while 13% are uncertain due to the stock's volatility.
Stocktwits
News Placeholder
Phio Pharma Stock Quadruples On Positive Data From Cancer Treatment Trial: Retail’s Elated
CEO Robert Bitterman highlighted the potential of Phio’s proprietary INTASYL RNAi technology, which targets proteins that hinder the body’s immune response to cancer.
Stocktwits
<
...
1
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available